REGENERON PHARMACEUTICALS

REGNNASDAQ

🏆 #166 by market capEarnings Oct 26Biotech

$467.83▲ $11.84 (+2.53%)

Simulated price

1h—

24h▲ 2.5%

7d—

14d—

30d—

1y—

🏦Market Cap

$83.19B

Mid Cap

📈Revenue Growth (YoY)

+9.3%

Slowing

📊Gross Margin

86.0%

High

💵FCF Margin

23.0%

Strong

⚖️P/S Ratio

5.3x

Fair

Otter Score

59

Weak

🔭

No analyst ratings for REGN

We don't have Wall Street analyst coverage for this ticker yet. Ratings and price targets appear here as firms publish them.